Michael A Bookman

No ORCID on file · 2 papers in corpus

other 2017

An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience

Gynecologic Oncology ·doi:10.1016/j.ygyno.2017.08.004

PURPOSE: We examined disparities in prognosis between patients with ovarian clear cell carcinoma (OCCC) and serous epithelial ovarian cancer (SOC). METHODS: We reviewed data from FIGO stage I-IV epithelial ovarian cancer patients who parti…

review 2014

Better therapeutic trials in ovarian cancer

Journal of the National Cancer Institute ·doi:10.1093/jnci/dju029

The Ovarian Task Force of the Gynecologic Cancer Steering Committee convened a clinical trials planning meeting on October 28-29, 2011, with the goals to identify key tumor types, associated molecular pathways, and biomarkers for targeted d…